FATE THERAPEUTICS INC

Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting

22 апр 2024 16:30:00 Источник Nasdaq GlobeNewswire

Fate Therapeutics to Present at 23rd Annual Needham Virtual Healthcare Conference

03 апр 2024 08:00:00 Источник Nasdaq GlobeNewswire

Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

02 апр 2024 16:01:00 Источник Nasdaq GlobeNewswire

Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement

19 мар 2024 08:44:41 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: FATE THERAPEUTICS INC. - COMMON STOCK

07 мар 2024 15:11:47 Источник NetDania Notify

Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

05 мар 2024 16:01:00 Источник Nasdaq GlobeNewswire

Fate Therapeutics to Present at Upcoming March Investor Conferences

01 мар 2024 08:00:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: FATE THERAPEUTICS INC. - COMMON STOCK

27 фев 2024 09:45:16 Источник NetDania Notify

Fate Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates

26 фев 2024 16:01:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: FATE THERAPEUTICS INC. - COMMON STOCK

16 фев 2024 10:00:35 Источник NetDania Notify

NetDania - New 12 months High: FATE THERAPEUTICS INC. - COMMON STOCK

15 фев 2024 10:31:27 Источник NetDania Notify

Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2023 Financial Results

15 фев 2024 08:00:00 Источник Nasdaq GlobeNewswire

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

02 фев 2024 16:01:00 Источник Nasdaq GlobeNewswire

Fate Therapeutics Announces Initiation of Phase 1 Clinical Trial for FT825 / ONO-8250 in Patients with HER2-expressing Advanced Solid Tumors

08 янв 2024 08:00:00 Источник Nasdaq GlobeNewswire

Fate Therapeutics Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

13 дек 2023 17:00:00 Источник Nasdaq GlobeNewswire

Fate Therapeutics Reports Third Quarter 2023 Financial Results and Business Updates

08 ноя 2023 16:01:00 Источник Nasdaq GlobeNewswire

Fate Therapeutics to Webcast Conference Call Reporting Third Quarter 2023 Financial Results

25 окт 2023 08:00:01 Источник Nasdaq GlobeNewswire

Fate Therapeutics to Present at Upcoming September Investor Conferences

31 авг 2023 08:00:00 Источник Nasdaq GlobeNewswire

Fate Therapeutics Reports Second Quarter 2023 Financial Results and Business Updates

08 авг 2023 16:01:00 Источник Nasdaq GlobeNewswire

Fate Therapeutics to Webcast Conference Call Reporting Second Quarter 2023 Financial Results

28 июл 2023 08:00:00 Источник Nasdaq GlobeNewswire